How to Invest in Neuralink Before Its IPO Neuralink, founded by Elon Musk in 2016, is a neurotechnology company developing brain-computer interface (BCI) technology to revolutionize healthcare and human-AI integration. With recent milestones like successful human trials and a valuation of approximately $5 billion as of June 2023, Neuralink has captured significant investor interest. However, as a private company, its shares are not available on public stock exchanges, making direct investment challenging for retail investors. This article explores the limited options for investing in Neuralink before its potential initial public offering (IPO) and alternative ways to gain exposure to the neurotechnology sector. Why Neuralink Is Attracting Attention Neuralink aims to create implantable devices that enable direct communication between the human brain and computers, with applications like restoring mobility for individuals with paralysis and potentially enhancing cognitive abilities. The ...
Packed with practical advice on investments and wealth-building strategies, we’re here to help you succeed financially. Let's get rich together!